Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Zarate

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Molecular Psychiatry|March 12, 2014
Preliminary evidence that early reduction in p11 levels in natural killer cells and monocytes predicts the likelihood of antidepressant response to chronic citalopramP Svenningsson, L Berg, D Matthews, et al.
Molecular Psychiatry|October 12, 2016
cAMP signaling in brain is decreased in unmedicated depressed patients and increased by treatment with a selective serotonin reuptake inhibitorM Fujita, E M Richards, M J Niciu, et al.
Molecular Psychiatry|April 6, 2016
The role of adipokines in the rapid antidepressant effects of ketamineR Machado-Vieira, P W Gold, D A Luckenbaugh, et al.
Psychological Medicine|August 13, 2013
Fronto-limbic-striatal dysfunction in pediatric and adult patients with bipolar disorder: impact of face emotion and attentional demandsM A Brotman, W-L Tseng, A K Olsavsky, et al.
Molecular Psychiatry|May 31, 2017
Acute ketamine administration corrects abnormal inflammatory bone markers in major depressive disorderB Kadriu, P W Gold, D A Luckenbaugh, et al.
International Journal of Psychiatry in Clinical Practice|June 18, 2014
Treatment of bipolar depressive mood disorders: Algorithms for pharmacotherapyG M Goodwin, W A Nolen, M L Bourgeois, et al.
Translational Psychiatry|April 12, 2017
Animal models to improve our understanding and treatment of suicidal behaviorT D Gould, P Georgiou, L A Brenner, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2025
Dissecting heterogeneity in cortical thickness abnormalities in major depressive disorder: a large-scale ENIGMA MDD normative modelling studyJ M M Bayer, L S van Velzen, E Pozzi, et al.
Molecular Psychiatry|May 3, 2017
Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working GroupD P Hibar, L T Westlye, N T Doan, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Molecular Psychiatry|March 12, 2014
Preliminary evidence that early reduction in p11 levels in natural killer cells and monocytes predicts the likelihood of antidepressant response to chronic citalopramP Svenningsson, L Berg, D Matthews, et al.
Molecular Psychiatry|October 12, 2016
cAMP signaling in brain is decreased in unmedicated depressed patients and increased by treatment with a selective serotonin reuptake inhibitorM Fujita, E M Richards, M J Niciu, et al.
Molecular Psychiatry|April 6, 2016
The role of adipokines in the rapid antidepressant effects of ketamineR Machado-Vieira, P W Gold, D A Luckenbaugh, et al.
Psychological Medicine|August 13, 2013
Fronto-limbic-striatal dysfunction in pediatric and adult patients with bipolar disorder: impact of face emotion and attentional demandsM A Brotman, W-L Tseng, A K Olsavsky, et al.
Molecular Psychiatry|May 31, 2017
Acute ketamine administration corrects abnormal inflammatory bone markers in major depressive disorderB Kadriu, P W Gold, D A Luckenbaugh, et al.
International Journal of Psychiatry in Clinical Practice|June 18, 2014
Treatment of bipolar depressive mood disorders: Algorithms for pharmacotherapyG M Goodwin, W A Nolen, M L Bourgeois, et al.
Translational Psychiatry|April 12, 2017
Animal models to improve our understanding and treatment of suicidal behaviorT D Gould, P Georgiou, L A Brenner, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2025
Dissecting heterogeneity in cortical thickness abnormalities in major depressive disorder: a large-scale ENIGMA MDD normative modelling studyJ M M Bayer, L S van Velzen, E Pozzi, et al.
Molecular Psychiatry|May 3, 2017
Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working GroupD P Hibar, L T Westlye, N T Doan, et al.
Pageof 5